12 withdrawn. 12 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 12 | Withdrawn 12 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Pulmonary Fibrosis: new trials by email Literature Review of Pulmonary Fibrosis trials Research Report on Pulmonary Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Investigate Leramistat in Patients With IPF Leramistat, Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | Modern Biosciences Ltd | 2023-08-30 | 2025-04-09 | |
| A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis AMB-05X, Placebo - IPF | Phase 2 | Withdrawn | AmMax Bio, Inc. | 2023-03-01 | 2023-01-19 | |
| 129Xe Gas Exchange Imaging in IPF and cHP: A Reliability Study Hyperpolarized Xe129 - Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis | Phase 2 | Withdrawn | University of Kansas Medical Center | 2022-05-01 | 2022-09-10 | |
| Inhaled NAC in Treatment of IPF N-acetyl cysteine then Placebo, Placebo then N-acetyl cysteine - Idiopathic Pulmonary Fibrosis (IPF) | Phase 1 / Phase 2 | Withdrawn | University of Colorado, Denver | 2022-01-01 | 2021-06-08 | |
| Safety, Pharmacodynamics, and Pharmacokinetics of Orally Administered BLD-2660 in Subjects With IPF BLD-2660, Control: Placebo - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | Blade Therapeutics | 2019-12-15 | 2021-03-04 | |
| Oral Treprostinil in Subjects With Pulmonary Hypertension Associated With Pulmonary Fibrosis Oral treprostinil - Pulmonary Hypertension, Pulmonary Fibrosis | Phase 2 | Withdrawn | United Therapeutics | 2016-02-01 | 2016-02-09 | |
| A Study of Oral Vismodegib for the Treatment of Idiopathic Pulmonary Fibrosis (IPF) placebo, vismodegib - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | Hoffmann-La Roche | 2014-10-01 | 2016-11-02 | |
| A MultiCenter Study of Combined PEX, Rituximab, and Steroids in Acute Idiopathic Pulmonary Fibrosis Exacerbations Standard Steroid Treatment, The Standard Steroid Treatment, Plasma Exchange and rituximab - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | University of Pittsburgh | 2012-09-01 | 2016-01-05 | |
| Safety and Tolerability Study of Macitentan in Patients With Idiopathic Pulmonary Fibrosis Macitentan - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | Actelion | 2011-07-31 | 2025-06-22 | |
| Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA) STX-100 - Chronic Allograft Dysfunction | Phase 2 | Withdrawn | Stromedix, Inc. | 48 | 2010-09-01 | 2011-05-23 |
| Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis pomalidomide (CC-4047 - Pulmonary Fibrosis | Phase 2 | Withdrawn | Stanford University | 2010-04-01 | 2023-11-30 | |
| A Study Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of SM04646 Inhalation Solution in Subjects With Idiopathic Pulmonary Fibrosis (IPF) SM04646 - Idiopathic Pulmonary Fibrosis | Phase 2 | Withdrawn | Biosplice Therapeutics, Inc. | 1900-01-01 | 2018-10-09 |
Idiopathic Pulmonary Fibrosis (9) · Alveolitis, Extrinsic Allergic (1) · Hypertension, Pulmonary (1) · Respiratory Aspiration (1)
Lung Diseases (12) · Lung Diseases, Interstitial (12) · Respiratory Tract Diseases (12) · Pathologic Processes (5) · Pathological Conditions, Signs and Symptoms (5) · Fibrosis (4) · Cardiovascular Diseases (1) · Hypersensitivity (1) · Hypersensitivity, Immediate (1) · Hypertension (1) · Immune System Diseases (1) · Respiration Disorders (1) · Respiratory Hypersensitivity (1) · Vascular Diseases (1)
HhAntag691 (1) · Plasma Exchange (1) · Rituximab (1) · Xenon (1) · macitentan (1) · pomalidomide (1) · treprostinil (1)
Actelion (1) · AmMax Bio, Inc. (1) · Biosplice Therapeutics, Inc. (1) · Blade Therapeutics (1) · Hoffmann-La Roche (1) · Modern Biosciences Ltd (1) · Stanford University (1) · Stromedix, Inc. (1) · United Therapeutics (1) · University of Colorado, Denver (1) · University of Kansas Medical Center (1) · University of Pittsburgh (1)
United States (6) · United Kingdom (2) · Australia (1) · France (1) · Germany (1) · Greece (1) · Hungary (1) · Israel (1) · Italy (1) · New Zealand (1) · Spain (1)
Bradley Maroni, MD (1) · Dorothy Nguyen, MD (1) · Glenn D. Rosen (1) · Loic Perchenet, PhD (1) · Mark Steele, MD (1) · Rajan Saggar, MD (1) · Steven Duncan, MD (1) · Yusuf Yazici, M.D. (1)
2014 (1), 2023 (1)